Variable | %FO ≤ 0% | 0% < %FO ≤ 10% | 10% < %FO ≤ 20% | %FO>20% | P-value |
---|---|---|---|---|---|
Number, N (%) | 53 (17.2%) | 125 (40.5%) | 104 (33.6%) | 27 (8.7%) | |
Age (months, m), median (IQR) | 42.4 (14.9–88.3) | 18.5 (4.2–60.4)a,c | 7.5 (4.4–19.9)a | 5.8 (3.5–14.8)a | <0.001 |
Weight (kg) | 15.0 (9.5–25.0) | 11.0 (6.6–19.5) | 7.0 (5.4–11.0)a,b | 5.8 (4.9–8.2)a,b | <0.001 |
Gender, N (%) | 0.747 | ||||
Male | 29 (54.7%) | 77 (61.6%) | 63 (60.6%) | 18 (66.7%) | |
Female | 24 (45.3%) | 48 (39.4%) | 41 (39.4%) | 9 (33.3%) | |
Underlying disease, N (%) | 26 (49.1%) | 81 (64.8%) | 84 (80.8%)a,b | 23 (85.2%)a,b | <0.001 |
Reason for PICU admission, N (%) | 0.030 | ||||
Medical, N (%) | 39 (73.6%) | 85 (68.0%) | 57 (54.8%)a,b,d | 21 (77.8%) | |
Surgical, N (%) | 14 (26.4%) | 40 (32.0%) | 47 (45.2%)a,b,d | 6 (22.2%) | |
Receipt of CRRT, N (%) | 22 (41.5%) | 25 (20.0%)a | 7 (6.7%)a,b | 5 (18.5%)a | <0.001 |
Receipt of vasoactive drugs, N (%) | 38 (71.7%) | 62 (49.6%)a | 41 (39.4%)a,d | 17 (63.0%) | 0.001 |
No. of vasoactive drugs, median (IQR) | 2.0 (0.0–3.0)b,c | 1.0 (0.0–2.0) | 0.0 (0.0-1.0) | 1.0 (0.0–2.0) | <0.001 |
Diagnosis of MODS, N (%) | 28 (52.8%)b,c | 35 (28.0%) | 19 (18.3%) | 9 (33.3%) | 0.001 |
PRISM-III scores, median (IQR) | 8.0 (5.5–12.5)b,c | 4.0 (2.5–8.0) | 4.0 (1.0–8.0) | 5.0 (2.0–10.0) | 0.001 |
In-hospital mortality, N (%) | 17 (32.1%) | 31 (24.8%) | 21 (20.2%) | 12 (44.4%) | 0.053 |
Time from hospital admission to PICU (days), median (IQR) | 0.0 (0.0–5.0) | 0.0 (0.0–4.5) | 1.0 (0.0–5.0) | 0.0 (0.0–4.0) | 0.356 |
LOS in PICU (days), median (IQR) | 16.0 (9.0–22.0) | 16.0 (9.0–27.0) | 18.5 (10.0–31.0) | 21.0 (9.0–32.0) | 0.240 |
LOS in hospital (days), median (IQR) | 27.0 (18.5–42.0) | 25.0 (16.0–42.0) | 30.0 (18.0–46.8) | 27.0 (15.0–44.0) | 0.240 |
Time of MV, median (IQR) | 1 (1–1) | 1 (1–1) | 1 (1–1) | 1 (1–1) | 0.780 |
Duration of MV (days), median (IQR) | 5.0 (4.0–14.0) | 6.0 (4.0–11.0) | 7.0 (4.0–13.8) | 7.0 (5.0–14.0) | 0.733 |
Duration of first MV (days), median (IQR) | 5.0 (4.0–13.0) | 6.0 (4.0–10.0) | 7.0 (4.0–12.0) | 7.0 (5.0–14.0) | 0.625 |
Proportion of patients receiving MV for more than 7 days, N (%) | 20 (37.7%) | 46 (36.8%) | 47 (45.2%) | 11 (10.8%) | 0.616 |
Early FO, median (IQR) | −3.7 (−6.9 to − 1.2) | 5.8 (3.0–7.7) | 14.2 (12.0–16.9) | 23.1 (21.0–24.3) |